Paukner, S., Goldberg, L., Alexander, E., Das, A. F., Heinrich, S., Patel, P., Moran, G. J., Sandrock, C., File, T. M., Vidal, J. E., Waites, K. B., Gelone, S. P., & Schranz, J. (2022). pooled microbiological findings and efficacy outcomes by pathogen in adults with community-acquired bacterial pneumonia from the Lefamulin Evaluation Against Pneumonia (LEAP) 1 and LEAP 2 phase 3 trials of lefamulin versus moxifloxacin. Journal of global antimicrobial resistance, 29, 434–443. http://access.bl.uk/ark:/81055/vdc_100156721366.0x00000f